Search results for: 'CHINA pharmaceutical market'

This research service offers comprehensive discussions about the key approvals, mergers and acquisitions, product licensing deals, and digital partnerships of the pharmaceutical industry in 2022. A renewed focus on operational excellence and digital transformation will push top-line pharmaceutical industry growth and drive strong partnerships with ...

The global pharmaceutical industry is witnessing dynamic trends following the coronavirus pandemic and is adapting to new challenges and opportunities. This study analyzes the 2021 highlights in the global pharmaceutical industry and provides forecasts for the next year and beyond. It addresses the impact of innovative modalities, technologies, ...

CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...

Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners i...

This research service provides a detailed overview and analysis of ten specialty pharmaceutical companies. They have been chosen by taking into account certain critical indicators such as revenues, research and development (R&D) expenditure, current drug pipeline, earnings per share, stock price appreciation, return on investment, and net income.

The research service aims to analyse and assess the global generics pharmaceutical market, map the key trends and dynamics shaping the industry sector and provide strategic recommendations for the success of the market participants. With several key blockbuster drugs losing patent protection and new healthcare reforms being introduced by the Govern...

This research service examines the water and wastewater management related opportunities in the global pharmaceutical industry covering the buying pattern, market entry routes, distribution, technology, legislation, demand and geographical trends. Following from these, market growth for regional and market segments are forecasted. In addition, an i...

Geopolitical crises and high inflation prompted most central banks to raise interest rates in 2022, derailing the post-pandemic recovery. Energy costs increased manifold, impacting demand- and supply-side participants equally. Oil prices reached record highs as countries cut dependency on Russian imports, with the price of Brent crude oil reaching ...

This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It...